Table 13.11

Unadjusted Patient Survival, Heart-Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	73	78.1%	4.8%	73	67.1%	5.5%	92	41.3%	5.1%	98	36.7%	4.9%
Primary Diagnosis	Congenital Disease	31	74.2%	7.9%	31	71.0%	8.2%	35	51.4%	8.4%	47	38.3%	7.1%
	Primary Pulmonary Hypertension	15	86.7%	8.8%	15	80.0%	10.3%	18	44.4%	11.7%	15	40.0%	12.6%
	Cystic Fibrosis	0	-	-	0	-	-	1	0.0%	0.0%	3	66.7%	27.2%
	Emphysema/COPD	3	66.7%	27.2%	3	66.7%	27.2%	7	71.4%	17.1%	2	0.0%	0.0%
	Retransplant/Graft Failure	0	-	-	0	-	-	1	0.0%	0.0%	3	0.0%	0.0%
	Other	6	50.0%	20.4%	6	33.3%	19.2%	5	0.0%	0.0%	9	55.6%	16.6%
	Unknown	18	88.9%	7.4%	18	61.1%	11.5%	25	28.0%	9.0%	19	26.3%	10.1%

Source: OPTN/SRTR Data as of August 1, 2003.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2000-2001 for 3 month and 1 year; 1998-1999 for 3 year; and 1996-1997 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart-lung transplants.

Multi-organ transplants are excluded.